Showing results (11-20 of 110) with videos related to
Sort By:
Pageof 11
Nature Reviews. Cancer|September 25, 2013
Cancer drug resistance: an evolving paradigmCaitriona Holohan, Sandra Van Schaeybroeck, Daniel B Longley, et al.Current Molecular Medicine|February 22, 2008
The role of LEF/TCF factors in neoplastic transformationAmod Ravindranath, Angeline O'Connell, Patrick G Johnston, et al.Anticancer Research|May 22, 2004
5-Fluorouracil: identification of novel downstream mediators of tumour responseJohn Boyer, Pamela J Maxwell, Daniel B Longley, et al.Cancer Letters|June 28, 2005
The emerging role of CD44 in regulating skeletal micrometastasisAshleigh Hill, Suzanne McFarlane, Patrick G Johnston, et al.Apoptosis : an International Journal on Programmed Cell Death|September 25, 2008
Machine vision based stochastic analysis of cancer cell mitochondrial dysfunction induced by a BH3 domainAlex D Chacko, Nyree T Crawford, Patrick G Johnston, et al.Nature Reviews. Clinical Oncology|February 16, 2011
Implementing prognostic and predictive biomarkers in CRC clinical trialsSandra Van Schaeybroeck, Wendy L Allen, Richard C Turkington, et al.Personalized Medicine|May 24, 2018
Predictive and prognostic markers in colorectal cancerRichard C Turkington, Vicky M Coyle, Patrick G Johnston, et al.Lancet (London, England)|October 18, 2002
BRCA1: mechanisms of inactivation and implications for management of patientsRichard D Kennedy, Jennifer E Quinn, Patrick G Johnston, et al.Biological & Pharmaceutical Bulletin|July 17, 2004
Implication of CDK inhibitors p21 and p27 in the differentiation of HL-60 cellsNobuyuki Horie, Tsuyoshi Mori, Hidetsugu Asada, et al.Molecular Cancer Research : MCR|November 21, 2007
Interaction between transcription factor, basal transcription factor 3, and the NH2-terminal domain of human estrogen receptor alphaChris D Green, Paul D Thompson, Patrick G Johnston, et al.Pageof 11